EUVIMEDEUVIMED entdecken
Crossref

L26/P-683 Elevated late-follicular progesterone levels during ovarian stimulation for ART are associated with a lower euploid blastocyst rate

T. Horikawa, K. Nakagawa, K. Shiobara, H. Kataoka, T. Maruyama, S. Takamizawa, R. Sugiyama

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von T. Horikawa und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Can elevated progesterone levels in late-follicular phase during ovarian stimulation have a negative impact on embryo ploidy? Summary answer Higher late-follicular serum progesterone during ovarian stimulation is associated with a reduced euploid blastocyst rate. What is known already Late-follicular progesterone (P) elevation during ovarian stimulation has been associated with lower pregnancy rates due to endometrial maturation and embryo–endometrium asynchrony in fresh transfers. Consequently, it was expected that freeze-all with frozen embryo transfer (FET) would offset this effect. However, recent studies report lower pregnancy and cumulative pregnancy rates despite freeze-all. This progesterone-rise likely reflects follicular P ‘seeping’ into the circulation rather than premature luteinization. As progesterone increases with follicle number, we examined progesterone per follicle (P/fol) and previously found poorer FET outcomes with high P/fol was high (aOR 0.61, 95%CI 0.46-0.79, p < 0.001). We therefore assessed P/fol and embryo ploidy. Study design, size, duration This was a retrospective observational study conducted at the Sugiyama Clinic Shinjuku, which included patients who underwent ovarian stimulation for PGT-A between January 2021 and June 2025. Of the cycles involving ICSI, the study analyzed data from 1,396 women (across 2,848 cycles). The stimulation protocol primarily used a progesterone-primed protocol, with antagonist and clomiphene citrate–FSH regimens. Final oocyte maturation was triggered using either hCG, a GnRH agonist, or both. Participants/materials, setting, methods ICSI was performed following oocyte retrieval. The blastocysts underwent trophectoderm biopsy on days 5 or 6, after which ploidy was assessed by NGS. ‘Euploid’ was defined as ‘fully euploid’ and low-level mosaics were excluded. On the trigger day, the number of follicles measuring ≥18 mm was counted and serum P was measured; P/fol was calculated by dividing the serum P by follicle count. Multivariable regression assessed the independent association between P/fol and the euploid rate. Main results and the role of chance Unless otherwise stated, data are presented as mean ± SD. The mean female age was 40.2 ± 4.2 years. On the trigger day, the mean follicle count was 5.6 ± 3.6, with 7.9 ± 6.1 oocytes retrieved and 3.3 ± 3.0 blastocysts biopsied per cycle. A trophectoderm biopsy was performed on 9,490 blastocysts, yielding 1,927 euploid embryos (euploid rate: 20.3%). On the trigger day, the mean serum E2 level was 1,127.2 ± 1,017.4 pg/mL, the mean serum progesterone level was 1.0 ± 0.8 ng/mL and the mean P/fol ratio was 0.22 ± 0.19 ng/mL; the median P/fol ratio was 0.172 (interquartile range 0.115–0.265). Using a prespecified cut-off point, the cycles were classified as ‘High’ (P/FOL ≥0.30) or ‘Low’ (<0.30). The Low group had a lower mean female age (40.0±4.1 vs 41.3±3.5 years). The euploid rate was higher in the low group than in the high group (21.0% [1722/8187] vs. 15.7%). After adjusting for female age, anti-mullerian hormone (AMH), body mass index (BMI), number of oocytes retrieved, male age, and trigger-day E2 in a multivariable analysis, high P/FOL remained independently associated with a lower euploid rate (adjusted odds ratio (OR) 0.766; 95% confidence interval (CI) 0.611–0.960; p = 0.021). Limitations, reasons for caution Higher progesterone ‘seepage’, as estimated by serum P/fol was associated with a lower euploid rate. However, intrafollicular progesterone levels were not measured directly; our exposure metric relied on the assumption that circulating progesterone originated from growing follicles. Wider implications of the findings Protocol selection and progesterone monitoring during stimulation may help optimize euploid embryo yield, suggesting that late-follicular progesterone rise may impair embryo competence beyond endometrial asynchrony. Prospective studies should validate clinically actionable P/fol thresholds and determine whether progesterone is causal or a marker of follicular dysfunction. Trial registration number No

Zitieren

APA

Horikawa, T., Nakagawa, K., Shiobara, K., Kataoka, H., Maruyama, T., Takamizawa, S., & Sugiyama, R. (2026). L26/P-683 Elevated late-follicular progesterone levels during ovarian stimulation for ART are associated with a lower euploid blastocyst rate. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1013

Vancouver

Horikawa T, Nakagawa K, Shiobara K, Kataoka H, Maruyama T, Takamizawa S, et al. L26/P-683 Elevated late-follicular progesterone levels during ovarian stimulation for ART are associated with a lower euploid blastocyst rate. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1013

BibTeX
@article{Horikawa2026,
  author = {Horikawa, T. and Nakagawa, K. and Shiobara, K. and Kataoka, H. and Maruyama, T. and Takamizawa, S. and Sugiyama, R.},
  title = {L26/P-683 Elevated late-follicular progesterone levels during ovarian stimulation for ART are associated with a lower euploid blastocyst rate},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1013}
}
Kostenlos starten →